Stem cells aim to strengthen bones in High-Risk women
NCT ID NCT06949137
First seen Feb 17, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This early-stage study tests a new stem cell treatment (HMM910) in 9 postmenopausal women with osteoporosis who are at high risk of breaking a bone. The main goal is to see if the treatment is safe and tolerable. Researchers will also check how the stem cells move through the body and if they help improve bone health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HELP Therapeutics
Nanjing, Jiangsu, 210000, China
Conditions
Explore the condition pages connected to this study.